Regulation of Metformin Response by Breast Cancer Associated Gene 2
Adenosine monophosphate-activated protein kinase (AMPK), a master regulator of cellular energy homeostasis, has emerged as a promising molecular target in the prevention of breast cancer. Clinical trials using the United States Food and Drug Administration (FDA)-approved, AMPK-activating, antidiabe...
Main Authors: | Daniela Buac, Fathima R. Kona, Arun K. Seth, Q. Ping Dou |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2013-12-01
|
Series: | Neoplasia: An International Journal for Oncology Research |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1476558613800073 |
Similar Items
-
Metformin, AMPK and Breast Cancer
by: Hadad, Sirwan Mohammed
Published: (2010) -
Metformin as an adjuvant in breast cancer treatment
by: Mohsin HK Roshan, et al.
Published: (2019-07-01) -
Metformin as an anticancer agent in breast cancer therapy by regulating tumor associated macrophage polarization and function
by: CHIANG, CHI-FU, et al.
Published: (2017) -
Effect of metformin on breast cancer metabolism
by: Lord, Simon Richard
Published: (2014) -
Response of breast cancer cells and cancer stem cells to metformin and hyperthermia alone or combined.
by: Hyemi Lee, et al.
Published: (2014-01-01)